Clinical Trial Information
Disclaimer (Please read when viewing this page)
This page contains an overview of the clinical trials conducted by Nippon Shinyaku. The purpose of this page is to widely provide information on ongoing clinical trials to the general public, including patients and their families, and is not intended to advertise or promote our products.
The information posted here is based on data publicly available in the clinical trial registries such as jRCT and ClinicalTrials.gov. For detailed information on the clinical trials conducted or being conducted by Nippon Shinyaku, please check the link to each clinical trial registries.
Please note that the information posted here may differ from the latest information depending on the timing of updates.
Ongoing Clinical Trial
| Stage | Indications | Code No. (Generic name) |
Study No. | Recruitment status | Link to Clinical Trial Registries | |
|---|---|---|---|---|---|---|
| jRCT | ClinicalTrials.gov | |||||
| Phase IV | Blastic plasmacytoid dendritic cell neoplasm | NS-401 (tagraxofusp) |
NS401-P4-01 | Pending | jRCT2011250059 | － |
| Phase III | Arteriosclerosis obliterans | NS-304 (selexipag) |
NS304A-P3-1 | Pending | jRCT2071250134 | － |
| Phase III | Arteriosclerosis obliterans | NS-304 (selexipag) |
NS304A-P3-2 | Pending | jRCT2071250135 | － |
| Phase II | Eosinophilic granulomatosis with polyangiitis | NS-229 | NS229-P2-01 | Recruiting | jRCT2031230526 | NCT06046222 |
| Phase II | Duchenne muscular dystrophy | NS-089/NCNP-02 (brogidirsen) |
NS089/NCNP02-P2OE | Recruiting | jRCT2041250028 | NCT05996003 |
| Phase II | Duchenne muscular dystrophy | NS-089/NCNP-02 (brogidirsen) |
NS089/NCNP02-P2OE | Not Recruiting | jRCT2031210162 | NCT05135663 |
| Phase I/II | Blastic plasmacytoid dendritic cell neoplasm | NS-401 (tagraxofusp) |
NS401-P1-02 | Not Recruiting | jRCT2031220023 | － |
| Phase I/II | Duchenne muscular dystrophy | NS-050/NCNP-03 | NS-050/NCNP-03-101 | Recruiting | jRCT2041240060 | NCT06053814 |
| Phase I | Acute myeloid leukemia | NS-917 (radgocitabine) |
NS917-P1-01 | Not Recruiting | jRCT2031210452 | － |
| Phase I | Healthy volunteer | NS-229 | NS229-P1-05 | Recruiting | jRCT2071250080 | － |
| Phase I | Healthy volunteer | NS-229 | NS229-P1-06 | Pending | jRCT2071250131 | － |
| Phase I | Healthy volunteer | NS-245 | NS245-P1-01 | Recruiting | jRCT2071250086 | － |